These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30296882)

  • 1. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
    Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
    J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
    Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
    PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
    McManus L; Fisher JA
    AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.
    Manton KJ; Gauld CS; White KM; Griffin PM; Elliott SL
    BMJ Open; 2019 Jan; 9(1):e024224. PubMed ID: 30647042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
    Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
    Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
    Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
    J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.
    Edelblute HB; Fisher JA
    J Empir Res Hum Res Ethics; 2015 Feb; 10(1):65-75. PubMed ID: 25742668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.
    Fisher JA; Monahan T; Walker RL
    J Bioeth Inq; 2019 Dec; 16(4):535-549. PubMed ID: 31713712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why healthy subjects volunteer for phase I studies and how they perceive their participation?
    Almeida L; Azevedo B; Nunes T; Vaz-da-Silva M; Soares-da-Silva P
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1085-94. PubMed ID: 17891536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More than the money: a review of the literature examining healthy volunteer motivations.
    Stunkel L; Grady C
    Contemp Clin Trials; 2011 May; 32(3):342-52. PubMed ID: 21146635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
    Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
    Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typologies of Altruistic and Financial Motivations for Research Participation.
    Chin LJ; Berenson JA; Klitzman RL
    J Empir Res Hum Res Ethics; 2016 Oct; 11(4):299-310. PubMed ID: 28251864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
    Kalbaugh CA; Kalbaugh JM; McManus L; Fisher JA
    PLoS One; 2021; 16(9):e0256994. PubMed ID: 34492044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
    Fisher JA; McManus L; Kalbaugh JM; Walker RL
    Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials.
    Cottingham MD; Kalbaugh JM; Swezey T; Fisher JA
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1(Suppl 1):S30-S36. PubMed ID: 30222703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy for recruitment and factors associated with motivation and satisfaction in a randomized trial with 210 healthy volunteers without financial compensation.
    Luzurier Q; Damm C; Lion F; Daniel C; Pellerin L; Tavolacci MP
    BMC Med Res Methodol; 2015 Jan; 15():2. PubMed ID: 25559410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's reasons for participation in a clinical trial for menstrual pain: a qualitative study.
    Blödt S; Witt CM; Holmberg C
    BMJ Open; 2016 Dec; 6(12):e012592. PubMed ID: 27965251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Credibility and comprehension of healthy volunteers in lengthy inpatient drug studies.
    Apseloff G; Kitzmiller JP; Tishler CL
    Am J Ther; 2013; 20(3):257-60. PubMed ID: 23656966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.
    Turriff A; Blain D; Similuk M; Biesecker B; Wiley H; Cukras C; Sieving PA
    Am J Ophthalmol; 2019 Aug; 204():90-96. PubMed ID: 30885710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.